Dmitry Zamoryakhin
Chief Tech/Sci/R&D Officer bei BIODEXA PHARMACEUTICALS PLC
Profil
Dmitry Zamoryakhin is currently the Chief Scientific Officer at Biodexa Pharmaceuticals Plc since 2021.
Prior to this, he worked as the Chief Medical Officer at Oxford Biomedica Plc from 2018 to 2021 and as the Head-Development Strategy & Intelligence at Grünenthal GmbH from 2016 to 2018.
Dr. Zamoryakhin holds an MBA and a doctorate from Warwick Business School and a doctorate from Perm State Medical University.
Aktive Positionen von Dmitry Zamoryakhin
| Unternehmen | Position | Beginn |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 11.07.2021 |
Ehemalige bekannte Positionen von Dmitry Zamoryakhin
| Unternehmen | Position | Ende |
|---|---|---|
| OXFORD BIOMEDICA PLC | Chief Tech/Sci/R&D Officer | 01.01.2021 |
Grünenthal GmbH
 Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Corporate Officer/Principal | 01.08.2018 |
Ausbildung von Dmitry Zamoryakhin
| Warwick Business School | Doctorate Degree |
| Perm State Medical University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| OXFORD BIOMEDICA PLC | Health Technology |
| BIODEXA PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | Health Technology |
